11.2 Capital: A San Francisco-based venture capital fund, investing in and nurturing global tech startups.
Location
San Francisco, CA, US
Founded
2013
11.2 Capital is an early-stage venture capital fund based in San Francisco, focusing on global technology startups. They invest in founders solving significant global challenges, with a particular interest in breakthrough technologies across enterprise software, artificial intelligence, and biotechnology sectors. The firm typically participates in seed and Series A rounds, though they have also invested in later stages.
Notable portfolio companies include Ginkgo Bioworks, Hinge Health, and Forter. 11.2 Capital, named after Earth's escape velocity, aims to help startups achieve global impact. Their investment philosophy centers on supporting visionary founders tackling complex problems with innovative solutions, providing both capital and strategic guidance to accelerate growth and market penetration.
11.2 Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
